{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:59:21Z","timestamp":1770814761385,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K12578"],"award-info":[{"award-number":["24K12578"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bbrc.2025.152979","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:33:22Z","timestamp":1763444002000},"page":"152979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genomic insights and therapeutic efficacy of PARP inhibitors in a high-LOH patient-derived xenograft from malignant transformation of ovarian teratoma"],"prefix":"10.1016","volume":"792","author":[{"given":"Atsushi","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3130-3736","authenticated-orcid":false,"given":"Satoshi","family":"Tamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9879-0584","authenticated-orcid":false,"given":"Wang","family":"Xinyuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1484-4872","authenticated-orcid":false,"given":"Kosuke","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8662-9421","authenticated-orcid":false,"given":"Nobuhisa","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrc.2025.152979_bib1","first-page":"22","article-title":"Mature cystic teratoma: a linicopathologic evaluation of 517 cases and review of the literature","volume":"84","author":"Comerci","year":"1994","journal-title":"Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152979_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S1470-2045(08)70306-1","article-title":"Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data","volume":"9","author":"Hackethal","year":"2008","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152979_bib3","first-page":"1","article-title":"Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review","volume":"19","author":"Li","year":"2019","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bbrc.2025.152979_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00000478-198905000-00007","article-title":"Squamous cell carcinoma arising in mature cystic teratoma of the ovary","volume":"13","author":"Hirakawa","year":"1989","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152979_bib5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"The Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nat. Genet."},{"issue":"6127","key":"10.1016\/j.bbrc.2025.152979_bib6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152979_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.gde.2012.03.005","article-title":"Genome sequencing and cancer","volume":"22","author":"Mardis","year":"2012","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbrc.2025.152979_bib8","article-title":"Nivolumab for malignant transformation of ovarian mature cystic teratoma","volume":"44","author":"Yoshimura","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.bbrc.2025.152979_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2023.04.003","article-title":"Downregulating vaccinia-related kinase 1 by luteolin suppresses ovarian cancer cell proliferation by activating the p53 signaling pathway","volume":"173","author":"Chang","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152979_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jog.14596","article-title":"Establishment of a patient-derived xenograft model and cell line of malignant transformation of mature cystic teratoma of the ovary","volume":"47","author":"Tamauchi","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.bbrc.2025.152979_bib11","series-title":"Basic Concepts of Molecular Pathology [Internet]","year":"2009"},{"issue":"10106","key":"10.1016\/j.bbrc.2025.152979_bib12","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(17)32440-6","article-title":"Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Coleman","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152979_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1470-2045(16)30559-9","article-title":"Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial","volume":"18","author":"Swisher","year":"2017","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152979_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1186\/s12885-023-11626-3","article-title":"Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model","volume":"23","author":"Oda","year":"2023","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.bbrc.2025.152979_bib15","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.3390\/pharmaceutics14122761","article-title":"Optimization of the solvent and in vivo administration route of auranofin in a syngeneic non-small cell lung cancer and glioblastoma mouse model","volume":"14","author":"Freire","year":"2022","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.bbrc.2025.152979_bib16","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/neuonc\/noaa104","article-title":"Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial","volume":"22","author":"Hanna","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2025.152979_bib17","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3389\/fonc.2019.01097","article-title":"Preclinical studies comparing efficacy and toxicity of DNA repair inhibitors, olaparib, and AsiDNA, in the treatment of carboplatin-resistant tumors","volume":"9","author":"Herath","year":"2019","journal-title":"Front. Oncol."},{"issue":"98","key":"10.1016\/j.bbrc.2025.152979_bib18","doi-asserted-by":"crossref","first-page":"37080","DOI":"10.18632\/oncotarget.26354","article-title":"A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models","volume":"9","author":"Sun","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2025.152979_bib19","series-title":"AVMA Guidelines for the Euthanasia of Animals","author":"Leary","year":"2020"},{"issue":"7","key":"10.1016\/j.bbrc.2025.152979_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152979_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1476-4598-13-246","article-title":"Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors","volume":"13","author":"Louren\u00e7o","year":"2014","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.bbrc.2025.152979_bib22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1158\/1078-0432.CCR-10-1996","article-title":"Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations","volume":"17","author":"Saeki","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152979_bib23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1186\/1471-2164-11-576","article-title":"Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma","volume":"11","author":"Hu","year":"2010","journal-title":"BMC Genom."},{"key":"10.1016\/j.bbrc.2025.152979_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1025367","article-title":"Comprehensive genomic profiling: does timing matter?","volume":"13","author":"Thapa","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152979_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12916-021-02089-z","article-title":"Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer","volume":"19","author":"Zhao","year":"2021","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.bbrc.2025.152979_bib26","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/2159-8290.CD-20-1543","article-title":"Resistance to durvalumab and durvalumab plus tremelimumab is associated with functional STK11 mutations in patients with non\u2013small cell lung cancer and is reversed by STAT3 knockdown","volume":"11","author":"Pore","year":"2021","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152979_bib27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS -Mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152979_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12885-024-12130-y","article-title":"Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2025.152979_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1387896","article-title":"Prognostic implications of STK11 with different mutation status and its relationship with tumor-infiltrating immune cells in non-small cell lung cancer","volume":"15","author":"Zheng","year":"2024","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.bbrc.2025.152979_bib30","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1038\/s41388-020-1237-0","article-title":"XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary","volume":"39","author":"Tamura","year":"2020","journal-title":"Oncogene"},{"issue":"16","key":"10.1016\/j.bbrc.2025.152979_bib31","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/cncr.32079","article-title":"High EMSY expression defines a BRCA\u2010like subgroup of high\u2010grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum","volume":"125","author":"Hollis","year":"2019","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.bbrc.2025.152979_bib32","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1002\/cncr.32135","article-title":"Clarifying the role of EMSY in DNA repair in ovarian cancer","volume":"125","author":"Kondrashova","year":"2019","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bbrc.2025.152979_bib33","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1111\/cas.15754","article-title":"Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma","volume":"114","author":"Tamura","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2025.152979_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/cas.70022","article-title":"Single\u2010nucleus RNA sequencing and spatial transcriptomics for squamous cell carcinoma arising from ovarian mature teratoma","author":"Yoshida","year":"2025","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152979_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12920-022-01188-x","article-title":"Genetic diagnosis of pseudomyxoma peritonei originating from mucinous borderline tumor inside an ovarian teratoma","volume":"15","author":"Taguchi","year":"2022","journal-title":"BMC Med. Genom."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2501695X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2501695X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T10:05:55Z","timestamp":1770804355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2501695X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"alternative-id":["S0006291X2501695X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152979","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic insights and therapeutic efficacy of PARP inhibitors in a high-LOH patient-derived xenograft from malignant transformation of ovarian teratoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152979"}}